Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet IMOVAX POLIO injection suspension
- Product code:
- W58637001
- Quantity:
- 1
- Indicated for:
- prevention of poliomyelitis
- Route of administration:
- injectable
- Substance:
- inactivated trivalent poliomyelitis vaccine (vaccine)
- ATC
- J07BF03 — Antiinfectives for systemic use | Viral vaccines | Poliomyelitis vaccines
Precautions:
Additional monitoring
This medicine is subject to additional monitoring.
Refrigerated storage
Store in the refrigerator as instructed in the leaflet.
Protect from light
Store protected from light.
The inactivated trivalent polio vaccine (IPV) is used to prevent poliomyelitis, a viral disease caused by three serotypes of the poliovirus, which can lead to paralysis and other severe complications. The vaccine contains inactivated (killed) viruses from all three serotypes, which stimulate the immune system to produce specific antibodies against them, providing long-term protection.
The vaccine is administered intramuscularly or subcutaneously, usually in multiple doses, according to recommended vaccination schedules for children and adults. It is often combined with other vaccines as part of routine immunization programs.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The inactivated trivalent polio vaccine is an essential measure for the global eradication of poliomyelitis, helping to protect vulnerable populations and prevent the re-emergence of this devastating disease.
The vaccine is administered intramuscularly or subcutaneously, usually in multiple doses, according to recommended vaccination schedules for children and adults. It is often combined with other vaccines as part of routine immunization programs.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The inactivated trivalent polio vaccine is an essential measure for the global eradication of poliomyelitis, helping to protect vulnerable populations and prevent the re-emergence of this devastating disease.
General data about IMOVAX POLIO
- Substance:
- inactivated trivalent poliomyelitis vaccine
- Date of latest medicines list:
- 01-03-2022
- Product code:
- W58637001
- Pharmaceutical form:
- injection suspension
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.